OrbiMed’s BlossomHill Therapeutics BLSM Stock Holding History
Bought
Maintained
Sold
Other funds holding BLSM
OrbiMed's BLSM Position: Q3 2026 in Review
OrbiMed opened a new position in BlossomHill Therapeutics (BLSM) in Q3 2026: 2,714,279 shares worth $50.6M. The stake represents 0.92% of the portfolio and ranks #31 among its holdings.
39 funds tracked by Wall St. Rank hold BLSM as of Q3 2026.
- OrbiMed held 2,714,279 shares of BlossomHill Therapeutics worth $50.6M as of Q3 2026.
- BlossomHill Therapeutics was a new OrbiMed position in Q3 2026.
- BlossomHill Therapeutics made up 0.92% of OrbiMed's portfolio in Q3 2026, its #31 holding.
- 39 funds tracked by Wall St. Rank held BlossomHill Therapeutics as of Q3 2026.
Based on OrbiMed's 13F filing for Q3 2026, filed 16 Nov 2026.